Nov 20, 2018
Arena Pharmaceuticals to Participate in Upcoming Investor Conferences
Nov 15, 2018
Arena Pharmaceuticals and United Therapeutics Announce Global License Agreement for Ralinepag
Nov 13, 2018
Arena Pharmaceuticals Presented Preclinical Data for APD418 in Development for Treatment of Decompensated Heart Failure at American Heart Association Scientific Sessions
Nov 07, 2018
Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2018 Financial Results
Oct 31, 2018
Arena Pharmaceuticals to Release Third Quarter 2018 Financial Results and Provide Corporate Update on November 7
Oct 08, 2018
Arena Pharmaceuticals Presented Phase 2 Clinical Data for Etrasimod in Ulcerative Colitis at the American College of Gastroenterology Annual Meeting
Oct 08, 2018
2018 Pain Drug Development Pipeline Review: Post-Operative Pain, Fibromyalgia, Complex Regional Pain Syndrome (CRPS) and Visceral Pain
Oct 02, 2018
Arena Pharmaceuticals Reports Positive Long-Term Data from the Ongoing Open-Label Extension of the Phase 2 Trial Evaluating Ralinepag for Treatment of Pulmonary Arterial Hypertension
Sep 20, 2018
Arena Pharmaceuticals to Present at Upcoming Investor Conferences
Sep 17, 2018
Blood Pressure Disorders Drug Development Pipeline Review 2018 - Molecule Type, Molecular Target, Mechanism of Action and Route of Administration
Aug 29, 2018
Arena Pharmaceuticals to Present at Upcoming Investor Conferences
Aug 28, 2018
Arena Pharmaceuticals Presented Phase 1 Clinical Data for Ralinepag in Pulmonary Arterial Hypertension at the European Society of Cardiology
Aug 06, 2018
Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2018 Financial Results
Jul 30, 2018
Arena Pharmaceuticals to Release Second Quarter 2018 Financial Results and Provide Corporate Update on Monday, August 6
May 21, 2018
Arena Pharmaceuticals Announces Data Presentation for Ralinepag in Pulmonary Arterial Hypertension at the American Thoracic Society International Conference
May 01, 2018
Arena Pharmaceuticals and Outpost Medicine Enter into Licensing Agreement for Undisclosed Novel Compound
Apr 12, 2018
Arena Pharmaceuticals Announces Phase 2 Data Presentation for Ralinepag in Pulmonary Arterial Hypertension at the International Society for Heart and Lung Transplantation Annual Meeting
Mar 01, 2018
Arena Pharmaceuticals to Present Phase 1 and Preclinical Data on APD371 in Development for Treatment of Pain Associated with Crohn's Disease at American Pain Society Annual Scientific Summit
Jan 22, 2018
Arena Pharmaceuticals to Host Key Opinion Leader Event on S1P Modulation and Etrasimod in Autoimmune Diseases on January 29 in New York City
Dec 21, 2017
Arena Pharmaceuticals to Present at the 36th Annual J.P. Morgan Healthcare Conference on January 10